XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.1

REVENUE (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Total Revenue by Type and by U.S versus Rest of World

The following table presents detail regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):

			Three months ended March 31,
			2025																					2024
(in millions)			U.S.						RoW						Total									U.S.						RoW						Total
Hereditary Cancer			$	75.4					$	10.9					$	86.3								$	76.3					$	11.8					$	88.1
Tumor Profiling			26.0						3.3						29.3									23.9						7.0						30.9
Prenatal			49.2						0.1						49.3									44.1						0.2						44.3
Pharmacogenomics			31.0						—						31.0									38.9						—						38.9
Total revenue			$	181.6					$	14.3					$	195.9								$	183.2					$	19.0					$	202.2

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration